Genetics of Depression and Anxiety: What Do Clinicians Need to Know?
Recorded on December 6, 2018 | 12 to 1 pm EST (part 1)
Featuring: Dr. Jordan Smoller, MD, ScD
Dr. Jordan Smoller is the MGH Trustees Endowed Chair in Psychiatric Neuroscience, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health in Boston. He is Associate Chief for Research in the MGH Department of Psychiatry and Director of the Psychiatric and Neurodevelopmental Genetics Unit in the MGH Center for Genomic Medicine. Dr. Smoller is a Tepper Family MGH Research Scholar and also serves as Director of the Omics Unit of the MGH Division of Clinical Research and co-Director of the Partners HealthCare Biobank at MGH. He is a Principal Investigator of All of Us New England as part of the NIH All of Us Research Program. Dr. Smoller is an author of more than 300 scientific publications and is also the author of The Other Side of Normal (HarperCollins/William Morrow, 2012).
In this webinar, Dr. Smoller will describe the current status of psychiatric genetic research with a focus on depressive and anxiety disorders. Dr. Smoller will review implications of this work for clinical practice, including the prospects and limitations of genetic or pharmacogenetic testing. He will also describe the potential for extending a precision medicine approach to the realm of depression and anxiety disorders.
- Summarize progress in identifying the genetic basis of psychiatric disorders;
- Understand the implications of psychiatric genetics for clinical practice
- Discuss the current status of pharmacogenetic testing for psychiatric drug use.
This webinar is eligible for CE.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
This course is co-sponsored by Amedco and Anxiety and Depression Association of American (ADAA). Amedco is approved by the American Psychological Association to sponsor continuing education for psychologists. Amedco maintains responsibility for this program and its content. 1.0 hours.
New York Board for Social Workers
Amedco SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0115. 1.0 hours.
The Anxiety and Depression Association of American (ADAA) has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6872. Programs that do not qualify for NBCC credit are clearly identified. ADAA is solely responsible for all aspects of the programs.
The CAMFT board accepts credits from providers approved by the American Psychological Association (APA).